Nicotinic acetylcholine receptor probed with a photoactivatable agonist: improved labeling specificity by addition of CeIV/glutathione. Extension to laser flash photolabeling.
The molecular structure of Torpedo marmorata acetylcholine binding sites has been investigated previously by photoaffinity labeling. However, besides the nicotine molecule [Middleton et al. (1991) Biochemistry 30, 6987-6997], all other photosensitive probes used for this purpose interacted only with closed receptor states. In the perspective of mapping the functional activated state, we synthesized and developed a new photoactivatable agonist of nAChR capable of alkylation of the acetylcholine (ACh) binding sites, as reported previously [Kotzyba-Hibert et al. (1997) Bioconjugate Chem. 8, 472-480]. Here, we describe the setup of experimental conditions that were made in order to optimize the photolabeling reaction and in particular its specificity. We found that subsequent addition of the oxidant ceric ion (CeIV) and reduced glutathione before the photolabeling step lowered considerably nonspecific labeling (over 90% protection with d-tubocurarine) without affecting the binding properties of the ACh binding sites. As a consequence, irradiation at 360 nm for 20 min in these new conditions gave satisfactory coupling yields (7.5%). A general mechanism was proposed to explain the successive reactions occurring and their drastic effect on the specificity of the labeling reaction. Last, these incubation conditions can be extended to nanosecond pulsed laser photolysis leading to the same specific photoincorporation as for usual irradiations (8.5% coupling yield of ACh binding sites, 77% protection with carbamylcholine). Laser flash photocoupling of a diazocyclohexadienoyl probe on nAChR was achieved for the first time. Taken together, these data indicate that future investigation of the molecular dynamics of allosteric transitions occurring at the activated ACh binding sites should be possible.
Grutter
T
T
Laboratoire de Chimie Bio-Organique, UMR 7514 CNRS, Faculté de Pharmacie-Université Louis Pasteur Strasbourg, Illkirch, France.
Goeldner
M
M
Kotzyba-Hibert
F
F
D000818:Animals; D001665:Binding Sites; D002563:Cerium / Q000737:chemistry / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D003979:Diazonium Compounds / Q000737:chemistry; D005978:Glutathione / Q000737:chemistry / Q000378:metabolism*; D006873:Hydroquinones / Q000378:metabolism; D007834:Lasers; D008024:Ligands; D018722:Nicotinic Agonists / Q000737:chemistry / Q000378:metabolism*; D016877:Oxidants / Q000737:chemistry / Q000378:metabolism; D019920:Photoaffinity Labels / Q000737:chemistry / Q000378:metabolism*; D010782:Photolysis; D011809:Quinones / Q000378:metabolism; D011978:Receptors, Nicotinic / Q000737:chemistry / Q000378:metabolism*; D014101:Torpedo; D014316:Tritium
D003979:Diazonium Compounds; D006873:Hydroquinones; D008024:Ligands; D018722:Nicotinic Agonists; D016877:Oxidants; D019920:Photoaffinity Labels; D011809:Quinones; D011978:Receptors, Nicotinic; C119727:diazocyclohexadienoylpropyltrimethylammonium; C119728:hydroquinoylpropyl-trimethylammonium; C119729:quinoylpropyl-trimethylammonium; D014316:Tritium; D002563:Cerium; D005978:Glutathione